AzTrials
AzTrials

Joint(S) DegenerationRAAPCNCT05134038

Association Between Fear of Falling and Spinal Stiffness.

An observational study of Joint(S) Degeneration and Old Age; Atrophy, run by Hopital of Melun at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

1. / evaluation of the fear of falling using an FES-I questionnaire, distribution of subjects according to the score into 3 groups (16-19: little concerned by the fear of falling, 20-27 moderately concerned, 28-64 very concerned by fear of falling) 2. Read more about this study

Who is it for?
Ages 75 years and olderHealthy volunteers can take part
What is being tested?
anthropomorphic measurements
How many people
100 participants
Where
1 siteFrance
Study dates
1 Dec 2021to 1 Jan 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 75 years and older
  • All sexes
  • Healthy volunteers accepted
  • Older adult

Study population: > 75 ans, in any geriatric department of the hospital

Who may be able to join

  • over 75 years old,
  • Ability to understand and answer a questionnaire in French
  • Ability to stand up
  • Patient from the Melun hospital (santé pole center + nursing home of the GHSIF)
  • Affiliated with a social security scheme

Who cannot join

  • mental disorders,
  • lumbar surgery

Trial locations and contacts

1 site in 1 country.

France1 site
  • GH Sud Ile-de-France, CH Melun-Sénart

    Melun, France, 77000

Other trials in France

About this study

Official title: L'impact De La Raideur Articulaire Pelvienne Sur La Peur De Chuter Du Sujet Âgé Hospitalisé Ou En Institution.

  1. / evaluation of the fear of falling using an FES-I questionnaire, distribution of subjects according to the score into 3 groups (16-19: little concerned by the fear of falling, 20-27 moderately concerned, 28-64 very concerned by fear of falling)
  2. / evaluation of lumbar articular mobility by the schober index, coxofemoral by hip goniometry in flexion and extension (no evaluation of other amplitudes because lack of abduction / abduction / external and internal rotation of the hip remain functional in walking and the balance)
Read the detailed description
  1. / evaluation of the fear of falling using an FES-I questionnaire, distribution of subjects according to the score into 3 groups (16-19: little concerned by the fear of falling, 20-27 moderately concerned, 28-64 very concerned by fear of falling)
  2. / evaluation of lumbar articular mobility by the schober index, coxofemoral by hip goniometry in flexion and extension (no evaluation of other amplitudes because lack of abduction / abduction / external and internal rotation of the hip remain functional in walking and the balance)
Being tested
anthropomorphic measurements
Medical subject headings
Joint Diseases, Atrophy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • anthropomorphic measurementsDiagnostic test

    Also called FES questionnaire

    anthropomorphic measurements + FES questionnaire + demographic data and medications

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Association FES and goniometry

    Highlight a significant positive association between hips' goniometry (angle degree) and FES-I score (continuous scale without unit)

    Measured: 15 minutes

  2. Association FES-I (continuous scale without unit) and Schober index (centimeter)

    Highlight a significant positive association between Shober index and FES-I score

    Measured: 15 minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Nov 2021
  2. Study start1 Dec 2021
  3. Primary completion1 May 2022
  4. Study completion1 Jan 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
100 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05134038
Sponsor's protocol ID
294-URC-GHSIF
Acronym
RAAPC
Status last verified
Sep 2024
First submitted
23 Oct 2021
Last updated
19 Sep 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Tinetti ME, Powell L. Fear of falling and low self-efficacy: a case of dependence in elderly persons. J Gerontol. 1993 Sep;48 Spec No:35-8. doi: 10.1093/geronj/48.special_issue.35. No abstract available.

    PubMed 8409238
  • Kendrick D, Kumar A, Carpenter H, Zijlstra GA, Skelton DA, Cook JR, Stevens Z, Belcher CM, Haworth D, Gawler SJ, Gage H, Masud T, Bowling A, Pearl M, Morris RW, Iliffe S, Delbaere K. Exercise for reducing fear of falling in older people living in the community. Cochrane Database Syst Rev. 2014 Nov 28;2014(11):CD009848. doi: 10.1002/14651858.CD009848.pub2.

    PubMed 25432016
  • Delbaere K, Close JC, Mikolaizak AS, Sachdev PS, Brodaty H, Lord SR. The Falls Efficacy Scale International (FES-I). A comprehensive longitudinal validation study. Age Ageing. 2010 Mar;39(2):210-6. doi: 10.1093/ageing/afp225. Epub 2010 Jan 8.

    PubMed 20061508
  • Laizeau C, Jochmans S, Aufaure S. Pelvic joint stiffness and fear of falling in patients over 75 years of age: a prospective cohort study of 100 patients. J Osteopath Med. 2024 May 8;124(11):481-486. doi: 10.1515/jom-2024-0004. eCollection 2024 Nov 1.

    PubMed 38713850

Questions about this trial

What is this clinical trial studying?

An observational study of Joint(S) Degeneration and Old Age; Atrophy, run by Hopital of Melun at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 19 Sep 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Association FES and goniometry (time frame: 15 minutes). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05134038, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Sep 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in